Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) saw a large decline in short interest in the month of October. As of October 15th, there was short interest totalling 151,400 shares, a decline of 10.9% from the September 30th total of 169,900 shares. Based on an average daily trading volume, of 110,400 shares, the short-interest ratio is currently 1.4 days.
Analysts Set New Price Targets
A number of brokerages have recently commented on CCAP. Bank of America cut their price target on Crescent Capital BDC from $20.00 to $19.00 and set a "buy" rating for the company in a report on Thursday, August 15th. LADENBURG THALM/SH SH assumed coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They issued a "buy" rating and a $20.00 price target for the company. Finally, Wells Fargo & Company decreased their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 14th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $19.00.
Read Our Latest Report on Crescent Capital BDC
Institutional Investors Weigh In On Crescent Capital BDC
A number of large investors have recently bought and sold shares of CCAP. Confluence Investment Management LLC raised its position in Crescent Capital BDC by 3.0% in the 2nd quarter. Confluence Investment Management LLC now owns 71,623 shares of the company's stock valued at $1,345,000 after purchasing an additional 2,108 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in Crescent Capital BDC during the 2nd quarter worth about $90,000. Sumitomo Mitsui Trust Holdings Inc. grew its holdings in Crescent Capital BDC by 14.1% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 80,766 shares of the company's stock worth $1,517,000 after acquiring an additional 10,000 shares during the last quarter. XTX Topco Ltd acquired a new stake in Crescent Capital BDC in the 2nd quarter valued at about $195,000. Finally, Catalina Capital Group LLC bought a new position in shares of Crescent Capital BDC in the second quarter worth about $220,000. 49.46% of the stock is currently owned by institutional investors.
Crescent Capital BDC Price Performance
NASDAQ CCAP traded down $0.20 on Tuesday, reaching $18.30. The company's stock had a trading volume of 94,684 shares, compared to its average volume of 132,509. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.17. The firm has a market cap of $678.23 million, a PE ratio of 6.51 and a beta of 0.81. Crescent Capital BDC has a 52 week low of $15.44 and a 52 week high of $19.63. The business has a 50-day moving average price of $18.43 and a 200 day moving average price of $18.32.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last posted its earnings results on Monday, August 12th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.01. Crescent Capital BDC had a net margin of 51.61% and a return on equity of 12.03%. The business had revenue of $48.95 million for the quarter, compared to analyst estimates of $48.05 million. During the same quarter in the prior year, the firm earned $0.56 EPS. Sell-side analysts expect that Crescent Capital BDC will post 2.35 EPS for the current year.
Crescent Capital BDC Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Monday, September 30th were paid a $0.42 dividend. The ex-dividend date was Monday, September 30th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 9.18%. This is a boost from Crescent Capital BDC's previous quarterly dividend of $0.09. Crescent Capital BDC's payout ratio is 59.79%.
About Crescent Capital BDC
(
Get Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.